Mitochondrial Dynamics Modulation via MyoAAV-Mediated OPA1 Overexpression or BNIP3 Knockdown in Pancreatic Ductal Adenocarcinoma (PDAC)-Induced Cachexia

Disruption of mitochondrial dynamics and quality control precedes overt muscle wasting in cancer cachexia, but whether modulating it specifically in muscle in the presence of systemic wasting could preserve tissue mass and function remain elusive. We tested two independent, but complementary approaches in the orthotopic preclinical model of pancreatic ductal adenocarcinoma (KPC); inducing inner-mitochondrial membrane fusion through OPA1 overexpression and suppressing mitophagy via BNIP3 knockdown. Male and female C57BL/6J mice received bilateral intramuscular tibialis anterior (TA) injections of myotropic adeno-associated virus (MyoAAV) encoding murine either OPA1 cDNA or a BNIP3-targeting short hairpin RNA two weeks prior to orthotopic implantation of KPC1245 pancreatic cancer cells. Raw body and tissue weights, in vivo dorsiflexor torque and fatigability, TA fiber size and type, protein fractional synthesis rate, oxidative histochemistry, and selected molecular markers were assessed at the humane endpoint. Neither intervention prevented systemic wasting, however, in males, OPA1 overexpression partially attenuated TA mass loss, relieved torque deficits, and restored the proportion of type IIB fibers. Females developed a milder cachectic phenotype; OPA1 overexpression increased TA mass and shifted fiber composition toward type IIA fibers without any changes in torque. In males, BNIP3 knockdown markedly improved torque, restored fatigue resistance, preserved type IIB fiber proportion, and lowered DRP1 protein. Functional benefits concurred by BNIP3 shRNA delivery were accompanied by lower mixed-protein synthesis in both sexes. These findings support mitochondrial quality control as a therapeutic target while indicating that effective treatment will require calibrated, rather than maximal, suppression of mitochondrial turnover.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.766453
Primary Topic
Muscle Physiology and Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Mitochondrial Dynamics Modulation via MyoAAV-Mediated OPA1 Overexpression or BNIP3 Knockdown in Pancreatic Ductal Adenocarcinoma (PDAC)-Induced Cachexia

Allie Ivy, Mary S. Jia, Tyrone A. Washington, Maryam Khaledabadi et al.
5 links
bioRxiv (Cold Spring Harbor Laboratory)
Muscle Physiology and Disorders
preprint

Mitochondrial Dynamics Modulation via MyoAAV-Mediated OPA1 Overexpression or BNIP3 Knockdown in Pancreatic Ductal Adenocarcinoma (PDAC)-Induced Cachexia

Allie Ivy, Mary S. Jia, Tyrone A. Washington, Maryam Khaledabadi, Francielly Morena da Silva, Ruqaiza Muhyudin, Christopher Nelson, Sydney Hilgenbrink, Nicholas P Greene, Nicole N Noga, Muskan Taori
preprint en

Abstract

Disruption of mitochondrial dynamics and quality control precedes overt muscle wasting in cancer cachexia, but whether modulating it specifically in muscle in the presence of systemic wasting could preserve tissue mass and function remain elusive. We tested two independent, but complementary approaches in the orthotopic preclinical model of pancreatic ductal adenocarcinoma (KPC); inducing inner-mitochondrial membrane fusion through OPA1 overexpression and suppressing mitophagy via BNIP3 knockdown. Male and female C57BL/6J mice received bilateral intramuscular tibialis anterior (TA) injections of myotropic adeno-associated virus (MyoAAV) encoding murine either OPA1 cDNA or a BNIP3-targeting short hairpin RNA two weeks prior to orthotopic implantation of KPC1245 pancreatic cancer cells. Raw body and tissue weights, in vivo dorsiflexor torque and fatigability, TA fiber size and type, protein fractional synthesis rate, oxidative histochemistry, and selected molecular markers were assessed at the humane endpoint. Neither intervention prevented systemic wasting, however, in males, OPA1 overexpression partially attenuated TA mass loss, relieved torque deficits, and restored the proportion of type IIB fibers. Females developed a milder cachectic phenotype; OPA1 overexpression increased TA mass and shifted fiber composition toward type IIA fibers without any changes in torque. In males, BNIP3 knockdown markedly improved torque, restored fatigue resistance, preserved type IIB fiber proportion, and lowered DRP1 protein. Functional benefits concurred by BNIP3 shRNA delivery were accompanied by lower mixed-protein synthesis in both sexes. These findings support mitochondrial quality control as a therapeutic target while indicating that effective treatment will require calibrated, rather than maximal, suppression of mitochondrial turnover.

bioRxiv (Cold Spring Harbor Laboratory)
University of Florida (US), University of Arkansas at Fayetteville (US)
Good health and well-being
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon